Author(s): Ryan BM, Robles AI, Harris CC
Abstract Share this page
Abstract Many studies have highlighted the role that microRNAs have in physiological processes and how their deregulation can lead to cancer. More recently, it has been proposed that the presence of single nucleotide polymorphisms in microRNA genes, their processing machinery and target binding sites affects cancer risk, treatment efficacy and patient prognosis. In reviewing this new field of cancer biology, we describe the methodological approaches of these studies and make recommendations for which strategies will be most informative in the future.
This article was published in Nat Rev Cancer
and referenced in Pancreatic Disorders & Therapy